Humans ; Olfaction Disorders/etiology* ; Smell

OBJECTIVE: To observe the effect of pharyngoplasty on olfactory and taste function in treating obstructive sleep apnea hypopnea syndrome (OSAHS). METHOD: Thirty-nine patients accepted pharyngoplasty for treating OSAHS from April 2005 to December 2005 who complained of olfactory and/or taste disturbances were analyzed in this study. RESULT: Four cases complained of taste disturbances , among them, one case complained of disturbance. The 1st case complained of hyposmia, complete taste loss of sour and salty and partial taste loss of sweet. The 2nd case complained of partial taste loss of sour, sweet, salty and bitter. The 3rd case complained of partial taste loss of sour. The 4th case complained of phantogeusia who had sour and bitter sensation in phlegm. CONCLUSION The olfactory and/or taste disturbances may be complications of pharyngoplasty. Surgeons should be careful during the operation to avoid the damage of olfactory and taste function.
Adult ; Humans ; Male ; Middle Aged ; Olfaction Disorders ; etiology ; Reconstructive Surgical Procedures ; adverse effects ; Sleep Apnea, Obstructive ; surgery ; Taste Disorders ; etiology

Acupuncture Therapy ; Aged ; Female ; Humans ; Middle Aged ; Olfaction Disorders ; etiology ; physiopathology ; therapy ; Sinusitis ; complications ; Smell

Chronic Disease ; Endoscopy ; adverse effects ; Humans ; Olfaction Disorders ; etiology ; Rhinitis ; psychology ; surgery ; Sinusitis ; psychology ; surgery

Olfaction is one of the ancient sensing capabilities and plays an important role in monitoring environment. Although olfactory loss is common, it's obviously underappretiated by medical community generally. In order to help patients with those problems, the author gives an brief review about the characters of common etiologies, treatment and prognosis of Olfactory Dysfunction. It's concluded that most usual causes resulting in dysos- mia are upper-respiratory-tract infections, trauma, and chronic rhinosinusitis; and our understanding of the olfaction mechanism grows, but frustratingly, aside from the possible therapeutic potential of systemic steroids, no method has been proved to have solid evidence for curing olfactory loss; so we need more new basic and clinic research to develop effective therapeutic intervention.
Chronic Disease ; Humans ; Olfaction Disorders ; etiology ; therapy ; Prognosis ; Respiratory Tract Infections ; Sinusitis ; Smell

Objective: The scientific community knows little about the long-term influence of coronavirus disease 2019 (COVID-19) on olfactory dysfunction (OD). With the COVID-19 pandemic ongoing worldwide, the risk of imported cases remains high. In China, it is necessary to understand OD in imported cases. Methods: A prospective follow-up design was adopted. A total of 11 self-reported patients with COVID-19 and OD from Xi'an No. 8 Hospital were followed between August 19, 2021, and December 12, 2021. Demographics, clinical characteristics, laboratory and radiological findings, and treatment outcomes were analyzed at admission. We surveyed the patients via telephone for recurrence and sequelae at the 1-, 6-, and 12-month follow-up. Results: Eleven patients with OD were enrolled; of these, 54.5% (6/11) had hyposmia and 45.5% (5/11) had anosmia. 63.6% (7/11) reported OD before or on the day of admission as their initial symptom; of these, 42.9% (3/7) described OD as the only symptom. All patients in the study received combined treatment with traditional Chinese medicine and Western medicine, and 72.7% (8/11) had partially or fully recovered at discharge. In terms of OD recovery at the 12-month follow-up, 45.5% (5/11) reported at least one sequela, 81.8% (9/11) had recovered completely, 18.2% (2/11) had recovered partially, and there were no recurrent cases. Conclusions Our data revealed that OD frequently presented as the initial or even the only symptom among imported cases. Most OD improvements occurred in the first 2 weeks after onset, and patients with COVID-19 and OD had favorable treatment outcomes during long-term follow-up. A better understanding of the pathogenesis and appropriate treatment of OD is needed to guide clinicians in the care of these patients.
COVID-19/complications* ; Follow-Up Studies ; Humans ; Olfaction Disorders/etiology* ; Pandemics ; Prospective Studies ; SARS-CoV-2

Objective: To observe the changes of olfactory function, intranasal trigeminal nerve function and taste function in patients with upper respiratory tract post-viral olfactory dysfunction (PVOD), and to explore the correlation of chemosensory function. Methods: The clinical data of 42 patients with PVOD who visited to the Olfactory and Taste Center of Otorhinolaryngology Head and Neck Surgery Department of Beijing Anzhen Hospital from January to December of 2019 were analyzed retrospectively, including 20 males and 22 females, aging (48.86±11.47) years (x¯). Twenty subjects in normal control group were selected according to the sex ratio of PVOD patients. Sniffin' Sticks olfactory tests were performed on the subjects, including threshold test (T), discrimination test (D) and identification test (I), and the sum of the above three test scores was the TDI value. At the same time, olfactory event-related potentials (oERPs), trigeminal event-related potentials (tERPs) and taste function test were performed. According to the taste function test, the patients were divided into normal gustation (NG) group and gustatory dysfunction (GD) group. The results of olfaction, taste and intranasal trigeminal nerve function tests were compared among different groups, and the correlation analysis was carried out. SPSS statistical software was used for statistical analysis. Results: GD was present in 14 (33.3%) of 42 PVOD patients with a course of PVOD of 5 (3, 6) months (M (Q₁, Q₃)). The gustatory function of patients with PVOD was related to gender (r=0.565, P<0.001), smoking status (r=-0.512, P=0.001), duration (r=-0.357, P=0.020) and olfactory function (all P<0.05). The olfactory function of GD group was worse than that of NG group, and the differences of TDI value and T value between the two groups were statistically significant (10.25±4.58 vs 13.35±3.61, 1.54±0.66 vs 2.10±0.88, t value was 2.40 and 2.10 respectively, both P<0.05). The amplitudes of oERPs and tERPs were significantly lower in GD group than those in NG group (all P<0.05). Conclusion: In patients with PVOD, the subjective and objective olfactory function, intranasal trigeminal nerve function and taste function were decreased, and there was a correlation, suggesting that there was a synergistic effect between the chemosensory functions of PVOD patients.
Female ; Humans ; Male ; Nose ; Olfaction Disorders/etiology* ; Retrospective Studies ; Smell ; Taste

OBJECTIVE: To observe the effects of moxa smoke through olfactory pathway on learning and memory ability in rapid aging (SAMP8) mice, and to explore the action pathway of moxa smoke. METHODS: Forty-eight six-month-old male SAMP8 mice were randomly divided into a model group, an olfactory dysfunction group, a moxa smoke group and an olfactory dysfunction + moxa smoke group, with 12 mice in each group. Twelve age-matched male SAMR1 mice were used as the blank group. The olfactory dysfunction model was induced in the olfactory dysfunction group and the olfactory dysfunction + moxa smoke group by intraperitoneal injection of 3-methylindole (3-MI) with 300 mg/kg, and the moxa smoke group and the olfactory dysfunction + moxa smoke group were intervened with moxa smoke at a concentration of 10-15 mg/m³ for 30 min per day, with a total of 6 interventions per week. After 6 weeks, the emotion and cognitive function of mice was tested by open field test and Morris water maze test, and the neuronal morphology in the CAI area of the hippocampus was observed by HE staining. The contents of neurotransmitters (glutamic acid [Glu], gamma-aminobutyric acid [GABA], dopamine [DA], and 5-hydroxytryptamine [5-HT]) in hippocampal tissue of mice were detected by ELISA. RESULTS: The mice in the blank group, the model group and the moxa smoke group could find the buried food pellets within 300 s, while the mice in the olfactory dysfunction group and the olfactory dysfunction + moxa smoke group took more than 300 s to find them. Compared with the blank group, the model group had increased vertical and horizontal movements (P<0.05) and reduced central area residence time (P<0.05) in the open field test, prolonged mean escape latency on days 1-4 (P<0.05), and decreased search time, swimming distance and swimming distance ratio in the target quadrant of the Morris water maze test, and decreased GABA, DA and 5-HT contents (P<0.05, P<0.01) and increased Glu content (P<0.05) in hippocampal tissue. Compared with the model group, the olfactory dysfunction group had increased vertical movements (P<0.05), reduced central area residence time (P<0.05), and increased DA content in hippocampal tissue (P<0.05); the olfactory dysfunction + moxa smoke group had shortened mean escape latency on days 3 and 4 of the Morris water maze test (P<0.05) and increased DA content in hippocampal tissue (P<0.05); the moxa smoke group had prolonged search time in the target quadrant (P<0.05) and increased swimming distance ratio, and increased DA and 5-HT contents in hippocampal tissue (P<0.05, P<0.01) and decreased Glu content in hippocampal tissue (P<0.05). Compared with the olfactory dysfunction group, the olfactory dysfunction + moxa smoke group showed a shortened mean escape latency on day 4 of the Morris water maze test (P<0.05). Compared with the moxa smoke group, the olfactory dysfunction + moxa smoke group had a decreased 5-HT content in the hippocampus (P<0.05). Compared with the blank group, the model group showed a reduced number of neurons in the CA1 area of the hippocampus with a disordered arrangement; the olfactory dysfunction group had similar neuronal morphology in the CA1 area of the hippocampus to the model group. Compared with the model group, the moxa smoke group had an increased number of neurons in the CA1 area of the hippocampus that were more densely packed. Compared with the moxa smoke group, the olfactory dysfunction + moxa smoke group had a reduced number of neurons in the CA1 area of the hippocampus, with the extent between that of the moxa smoke group and the olfactory dysfunction group. CONCLUSION The moxa smoke could regulate the contents of neurotransmitters Glu, DA and 5-HT in hippocampal tissue through olfactory pathway to improve the learning and memory ability of SAMP8 mice, and the olfactory is not the only effective pathway.
Male ; Animals ; Mice ; Olfactory Pathways ; Smoke/adverse effects* ; Serotonin ; Aging ; Dopamine ; Olfaction Disorders/etiology*

In addition to acute respiratory symptoms,coronavirus disease 2019(COVID-19)could cause olfactory dysfunction,which becomes the only clinical manifestation of COVID-19 in some cases.We review the epidemiological characteristics,pathological mechanism,screening value,treatment and prognosis of olfactory dysfunction in patients with COVID-19,aiming to achieve an in-depth understanding of the early diagnosis,quarantine,scientific treatment and prognosis of COVID-19.
COVID-19 ; Early Diagnosis ; Humans ; Olfaction Disorders/etiology* ; SARS-CoV-2 ; Smell

OBJECTIVEThe study focus on the olfactory changes post upper respiratory infection, through observation of nasal mucosa and it's ultrastructural changes.

METHODSOlfactory test was performed by odor threshold and identification test (T&T olfactometry). The specimens of olfactory epithelium (OE) were obtained from 10 patients with anosmia or olfactory disorder post upper respiratory infection. All specimens were obtained under endoscope. Transmission electron microscope (TEM) was used to observe the ultrastructural changes of each group.

RESULTSUnder the TEM, the surface ultrastructure of the OE from patients showed following abnormal changes: (1) Normal epithelium structural characteristics maintained but clearance between cells appeared wider. (2) Olfactory vesicles reduced obviously, even if the olfactory vesicles existed, the olfactory cilia showed reduction. Some olfactory vesicles still existed, but the number of olfactory cilia reduced. Some olfactory vesicles changed their shape due to vacuolization. (3) Surface microvillus of the supporting cells disappeared. (4) The nuclei of supporting cell changed the shape or karyopyknosis, olfactory dendrites were shorter and wider than normal, and organelles reduced.

CONCLUSIONSThere is close relationship between ultrastructural changes and olfactory disorders post upper respiratory infection. Reduced olfactory vesicles, cilia and disappeared microvillus of the supporting cells are the main reasons for the patient's olfactory disorder.

Adult ; Common Cold ; complications ; Female ; Humans ; Male ; Microscopy, Electron, Transmission ; Middle Aged ; Olfaction Disorders ; etiology ; pathology ; Olfactory Mucosa ; ultrastructure